US4443476AExpiredUtility

Treatment of adult respiratory distress syndrome

Assignee: UPJOHN COPriority: Jul 20, 1981Filed: Dec 6, 1982Granted: Apr 17, 1984

Est. expiryJul 20, 2001(expired)· nominal 20-yr term from priority

Inventors:Pavel L. Lomen

C07C 57/58A61K 31/19C07C 57/30

PatentIndex Score

Cited by

References

Claims

Abstract

A process for treating adult respiratory distress syndrome by the systemic administration of flurbiprofen (3-fluoro-4-phenylhydratropic acid) or a salt or ester thereof. Dosage forms are also disclosed.

Claims

exact text as granted — not AI-modified

I claim: 
     
       1. A process for treating adult respiratory distress syndrome comprising the systemic administration to a human or animal having adult respiratory distress syndrome of an effective amount of 3-fluoro-4-phenylhydratropic acid or an alkyl ester of from 1 to 8 carbon atoms, inclusive, including isomeric forms thereof, or a pharmacologically acceptable salt thereof. 
     
     
       2. The process of claim 1 wherein the compound is 3-fluoro-4-phenylhydratropic acid.

Join the waitlist — get patent alerts

Track US4443476A — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.